DSCAM-AS1 positively correlated genes were significantly associated with clinical signatures associated with increased cancer aggression, tamoxifen resistance, higher grade, stage and metastasis (Fig. 3a,b, Supplementary Data 3 and 4). This evidence concerns the gene DSCAM-AS1 and cancer.